What Are Talking Labels, and Why Do They Matter?
Talking Labels are voice-recordable labels that can be applied directly to medication packaging. Any person — a pharmacist, a carer, a GP surgery, or a family member — can record spoken medication instructions onto the label at the touch of a button. The patient then simply presses the label to hear clear, personalised audio instructions for their medication. The concept is simple, but the need for it has never been more urgent.
The Government Has Identified the Problem — But Who Is Providing the Solution?
In March 2026, the Medicines and Healthcare products Regulatory Agency (MHRA) published its Improving Patient Information project on the UK Government website. (Link to web page). The MHRA committed to leading a fully inclusive approach to improving medicines information for everyone, stating that the information patients receive about their medicines should be clear, accessible, and support informed conversations between patients and their healthcare professionals.
The project adopts five design principles to guide its work: patient centred, accessible, trusted, innovative, and standardised — with a major focus on improving access to patient information through digital solutions.
These are admirable ambitions. Yet while the MHRA maps out a three-phase delivery plan stretching to 2028, millions of vulnerable people in the United Kingdom are right now struggling to safely manage their medication — today, tonight, and every day until that strategy is implemented.
The gap between policy intention and lived reality is not a minor administrative shortcoming. It is a patient safety crisis.
Organisations are Failing their Legal Obligations on Accessible Formats
The Equality Act 2010 places a clear legal duty on the NHS and organisations who prescribe medication, to make reasonable adjustments for disabled people. This includes providing information in Disabled Alternative Accessible Formats (D2AFs) — whether as Audio Electronic Formats (AEFs), Easy Read Formats (ERFs), Braille, or Large Print.
The reality, however, is deeply troubling. In the vast majority of cases across primary and secondary care, organisations are not providing prescription medication labels, patient information leaflets, or medicine safety warnings in any of these accessible formats. Patients who cannot read standard printed text — due to disability, visual impairment, cognitive conditions, or language barriers — are routinely issued medication with instructions they cannot access. This is not a fringe issue. It is a systemic failure.
Healthcare professionals, pharmacists, and commissioners have a duty to ask: when a patient cannot read their medication instructions, what obligation do we carry, and are we meeting it?
Accessibility Is Far Wider Than Audio, Braille, and Large Print
Public and institutional understanding of accessibility tends to cluster around three formats: audio, Braille, and large print. This framing is dangerously narrow.
Consider the scale of dyslexia alone. Approximately 1 in 10 people in the United Kingdom — between 6.8 million and 7 million individuals — live with some degree of dyslexia. For many of these people, reading standard printed medication instructions is genuinely difficult, inconsistent, or impossible under stress. Yet dyslexia is rarely considered when a pharmacist prints a label or a GP surgery issues discharge paperwork.
The accessibility challenge extends further still. The United Kingdom is home to substantial populations for whom English is an Additional Language (EAL). People from ethnic minority communities, recent arrivals, and long-term residents who communicate primarily in another language may receive medication information they cannot meaningfully understand. A label written in English, however clearly printed, provides no safety information to someone who reads in Urdu, Polish, Bengali, or Somali.
The NHS has an obligation to recognise these populations and to adapt. Currently, it is not doing so at the scale required.
The Risk Is Real: Wrong Medication, Wrong Dose, Serious Harm
When patients cannot understand their medication instructions, the consequences are not abstract. People take the wrong dose. They take medication at the wrong time. They combine medicines unsafely. They stop taking essential treatment because they do not understand why it is needed. In some cases, they take someone else's medication entirely. Voice-recordable Talking Labels directly address this risk. When instructions are recorded in a patient's own language, in the voice of a trusted carer or clinician, and are accessible with a single press of a button, the potential for misunderstanding is dramatically reduced. A patient does not need to read. They do not need to remember a complex verbal instruction. They simply press and listen.
How Talking Labels Work — and Why They Are So Easy to Use
Talking Labels require no technical expertise, no smartphone, no internet connection, and no specialist equipment. This is precisely what makes them so powerful in real-world healthcare settings. Here is how they work in practice:
Recording is straightforward. A pharmacist, GP, carer, or family member presses the record button and speaks the medication instructions clearly — name of patient, name of medication, dosage, timing, warnings, and any specific guidance. The message is stored directly on the label. Playback is immediate. The patient presses the label and hears the recorded message instantly. There are no menus to navigate, no screens to read, no passwords to remember. Application is universal. Talking Labels attach directly to medication packaging, exactly where the patient expects to find information. Recording can be done in any language. This single feature transforms the Talking Label from a useful accessibility tool into a genuinely inclusive medication safety solution for EAL patients and ethnic minority communities. Family members and carers can participate. A family member who visits weekly can re-record updated instructions as the prescription changes. A carer who knows the patient's language can record instructions in that language. The technology empowers those closest to the patient to contribute directly to their safety.
An Inclusive Approach to Medicines Information for Everyone
The MHRA's Improving Patient Information project acknowledges that placing patients at the centre of information design is the right direction. Talking Labels are one of the few commercially available solutions that can deliver on that principle today — without waiting for national strategy, regulatory change, or digital infrastructure investment.
For healthcare professionals researching medication management solutions, Talking Labels offer something rare: a device that works across the full spectrum of accessibility need. Whether the patient has a visual impairment, a cognitive disability, dyslexia, limited English proficiency, low health literacy, or simply struggles to retain complex spoken instructions — the Talking Label addresses each of these situations within a single, low-cost, immediately deployable format.
For relatives and carers supporting a loved one to manage medication safely and independently at home, Talking Labels offer genuine peace of mind. The ability to record your own voice — in your own words, in the right language, with the warmth and familiarity that printed labels can never carry — is something no pharmacy leaflet can replicate.
Talking Labels and the Commercially Available D2AF Requirement
Talking Labels qualify as a commercially available Disabled Alternative Accessible Format. They represent an Audio Electronic Format solution that can be sourced, purchased, and deployed by NHS organisations, pharmacies, GP surgeries, care homes, and community health providers — right now, without waiting for policy change.
For NHS commissioners and healthcare providers who are not currently making reasonable adjustments for patients unable to read printed medication instructions, Talking Labels represent both a practical solution and a step towards Equality Act compliance.
The Questions Every Healthcare Professional Should Be Asking
• Do you know which patients in your care cannot read their medication instructions?
• Are you currently providing medication information in any accessible format for those patients?
• Are you meeting your duty to make reasonable adjustments under the Equality Act 2010?
• What happens when a patient with dyslexia, a visual impairment, or limited English takes their medication home and cannot access the instructions?
If the honest answer to any of these questions is uncertain, Talking Labels are a practical, immediate, and inclusive starting point.
A Simple Solution to a Complex Problem
The MHRA has stated its commitment to making patient information clearer, more inclusive, and easier to understand. Talking Labels are ready to support that mission — not in 2027 or 2028, but right now.
For patients who cannot read. For carers who want to help. For healthcare professionals who recognise that accessible medication information is not an optional extra — it is a fundamental condition of safe care.
Talking Labels: press to hear, safe to take.
To learn more about Talking Labels and how they can be integrated into your medication management approach, contact the Customer Services Team at Talking Products Ltd using the details below.
Contact:
Talking Products Ltd
Unit C8 The Premier Centre
Abbey Park Ind. Estate
Romsey
Hampshire
SO51 9DG
Tel: 01794 278327
Email: info@TalkingProducts.com
Website: www.TalkingProducts.com
Related Topics: medication management, accessible healthcare, dyslexia and medication, NHS reasonable adjustments, patient safety, audio medication labels, disabled accessible formats, English as an Additional Language, healthcare, MHRA Improving Patient Information, voice recordable labels, inclusive medicines information